Is Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares a good investment? Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares (IINN) is currently trading at 0.9000 USD.
Earnings Schedule: Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is -0.70.
No, it does not currently pay a dividend.
Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -0.45.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Community Discussion